The global transfer membrane market is projected to reach 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5%. Factors such as increasing public and private funding for life science research, high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of this market. However, availability of advanced technologies for protein/nucleic acid quantification and analysis, featuring higher efficiency, end-to-end automation, and high-throughput capabilities (such as RT-PCR), have limited the use of analytical methods that use transfer membranes , which is expected to restrain the growth of the transfer membrane market in the forecast period.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=36975865
On the basis of type, the transfer membrane market is segmented into nylon membranes, nitrocellulose membranes, and PVDF membranes. In 2018, PVDF membranes are expected to command for the major share of the transfer membrane market. This can be attributed to the advantages of PVDF membranes over its counterparts, such as better protein retention, strength, chemical compatibility, and wide applications in western blotting.
The transfer membrane market, by transfer method, is segmented into tank electrotransfer, semi-dry electrotransfer, dry electrotransfer, and other transfer methods (diffusion blotting and vacuum blotting). In 2018, the tank electrotransfer segment is estimated to command the largest share of the transfer membrane market. The wide application of tank electrotransfer for clinical diagnostics and research is contributing to the growth of this market segment.
The transfer membrane market, by application, is segmented into southern blotting, northern blotting, western blotting, protein sequencing & amino acid analysis, and other applications. In 2018, the western blotting segment is expected to account for the largest share of the transfer membrane market. Rising incidence of autoimmune disease, allergy, and infectious diseases and significant application of western blotting in clinical diagnosis & post-treatment monitoring of these diseases are the major factors driving the growth of this market segment.
By region, the transfer membrane market is segmented into North America (US, Canada), Europe (Germany, France, UK and Rest of Europe), Asia Pacific (China, India, Japan, and Rest of Asia Pacific), and the Rest of the World (Middle-east & Africa, and Latin America). The Asia Pacific region is expected to grow at the highest rate during the forecast period. Factors such as the growing scale of life science projects funded by government and private bodies, and rising proteomic research in the region, are the major factors driving the growth of the Asia Pacific transfer membrane market.
